Cite
MLA Citation
L Dickinson et al.. “Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study.” Clinical pharmacology & therapeutics, vol. 98, no. 4, n.d., pp. 406–416. http://access.bl.uk/ark:/81055/vdc_100048667947.0x000056